Categories
Business FEATURED Health

AbbVie Inc. (NYSE:ABBV) and Allergan entered into conclusive transaction agreement

AbbVie Inc. (NYSE:ABBV) and Allergan plc announced that the companies have entered into a definitive transaction agreement under which AbbVie will acquire Allergan in a cash and stock transaction for a transaction equity value of approximately $63 billion.

AbbVie Inc. (NYSE:ABBV) shares slumped -16.25% to finally closed at $65.70 in last active session. 

ABBV’s distance from 20 day simple moving average is -15.54% and distance from 50-Day simple moving average is -16.43%.

Analyst’s mean target price for ABBV is $90.07 while analysts mean recommendation is 2.90. Stock value has moved between $73.82 – 99.55 in last one year. Stock has got OUTPERFORM rating from 3 of Thomson Reuters analysts, 11 given HOLD rating to the stock and 1 given UNDERPERFORM rating. Analyst’s mean target price for ABBV is $90.07 while analysts mean recommendation is 2.90. 

AbbVie Inc. (NYSE:ABBV) yearly performance is -29.73% and net profit margin is 16.30%. Annual EPS Growth of past 5 years is 7.60%. The current share price indicates that stock is -34.45% away from its one year high and is moving -10.99% ahead of its 52-week low. 



On 25 June 2018, Centene Corporation (NYSE:CNC) shares slumped -2.57% and ultimately finalized to $53.91 in last traded day. Stock has got OUTPERFORM rating from 7 of Thomson Reuters analysts, 2 given HOLD rating to the stock and 0 given UNDERPERFORM rating. Analyst’s mean target price for CNC is $73.50 while analysts mean recommendation is 1.70. 



At the movement The Lovesac Company (NASDAQ:LOVE) is under coverage by number of analysts. Buy rating has been given by 3 analysts to the company stock whereas 0 given UNDERPERFORM rating to stock and 0 given HOLD rating. The consensus recommendation by Thomson Reuters analysts is -0.50 and their mean rating for the stock is 1.40 on scale of 1-5. Analysts mean target price for The Lovesac Company (NASDAQ:LOVE) is $46.50 while their mean recommendation is 1.50 (1=Buy, 5=sell). 

If we look at stock performance in last active day trading, we see that stock has moved slumped -6.78% to end the day at $29.85. The current share price indicate that stock is -36.20% away from its one year high and is moving 81.35% ahead of its 52-week low. 

Leave a Reply